| 中文名 | 辛伐他汀酸(替尼伐他汀) |
|---|---|
| 英文名 | (3R,5R)-7-{(1S,2S,6R,8S,8aR)-8-[(2,2-Dimethylbutanoyl)oxy]-2,6-di methyl-1,2,6,7,8,8a-hexahydro-1-naphthalenyl}-3,5-dihydroxyheptan oic acid |
| 中文别名 |
辛伐他汀酸
替伐他汀 |
| 英文别名 |
Simvastatin Acid (Tenivastatin)
Lipex ZOCOR Tenivastatin (βR,δR,1S)-8α-(2,2-Dimethyl-1-oxobutoxy)-1,2,6,7,8,8aβ-hexahydro-β,δ-dihydroxy-2β,6α-dimethyl-1β-naphthalenehtanoic acid [14C]-Simvastatin acid 1-Naphthalenehtanoic acid, 8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-β,δ-dihydroxy-2,6-dimethyl-, (βR,δR,1S,2S,6R,8S,8) (3R,5R)-7-{(1S,2S,6R,8S,8-8-[(2,2-Dimethylbutanoyl)oxy]-2,6-di methyl-1,2,6,7,8,8a-hexahydro-1-naphthalenyl}-3,5-dihydroxyhtan oic acid Simvastatin Acid D6Q: What is Simvastatin Acid D6 Q: What is the CAS Number of Simvastatin Acid D6 (3R,5R)-3,5-Dihydroxy-7-[(1S)-1-(2,2-dimethylbutyryloxy)-3β,7α-dimethyl-1,2,3,7,8,8aα-hexahydronaphthalene-8α-yl]htanoic acid Benazolin-ethyl Impurity 14 2,2-Dimethylbutanoic acid [(1S)-1,2,3,7,8,8aα-hexahydro-3β,7α-dimethyl-8α-[(3R,5R)-3,5-dihydroxy-6-cboxyhexyl]naphthalen]-1β-yl ester (1S,3R,7S,8S,8-3,7-dimethyl-8-[2-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate 2,2-Dimethylbutyric acid (1S)-3β,7α-dimethyl-8α-[(3R,5R)-3,5-dihydroxy-6-cboxyhexyl]-1,2,3,7,8,8aα-hexahydronaphthalene-1β-yl ester [3H]-Simvastatin (3R,5R)-7-[(1S,2S,6R,8S,8-8-(2,2-dimethylbutanoyloxy)-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyhtanoic acid Lipovas simvastatin hydroxy acid Zocord Simcor Tenivastatincalcium Salt impurity (OR) Simvastatin impurity A simvastatin acid Eucor Denan Simvastatin hydroxy acid simvasterol 7-[1,2,6,7,8,8a(R)-hexahydro-2(S),6(R)-dimethyl-8(S)-[[2,2-dimethyl-butanoyl]oxy]-1(S)-naphthyl]-3(R),5(R)-dihydroxyheptanoic acid [3H]-Simvastatin acid [14C]-Simvastatin (3R,5R)-7-[(1S,2S,6R,8S,8-8-[(2,2-dimethylbutanoyl)oxy]-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyhtanoic acid (tenivastatin) Rechol |
| 描述 | 辛伐他汀酸(替尼伐他汀)是一种口服活性HMG-CoA还原酶(HMGCR)抑制剂。辛伐他汀酸可减少胆固醇合成,降低血液胆固醇水平[1]。辛伐他汀酸对癌细胞具有抗增殖活性并诱导凋亡[2]。 |
|---|---|
| 相关类别 | |
| 靶点 |
HMG-CoA reductase[1] |
| 体外研究 | 辛伐他汀酸(32和64μM;24、48和72小时)抑制肿瘤细胞生长,阻滞在G0/G1期[2]。辛伐他汀酸(32和64μM;48小时)诱导HepG2和Huh7细胞凋亡[2]。细胞增殖试验[2]细胞系:HepG2和Huh7细胞浓度:32和64μM孵育时间:24、48和72小时结果:与对照组相比,抑制肿瘤细胞生长(ctrl,p<0.05)。凋亡分析[2]细胞系:HepG2和Huh7细胞浓度:32和64μM孵育时间:48小时结果:早期凋亡从未处理的ctrl细胞的9.2%分别增加到18.2%(32μM)和19.8%(64μM),晚期凋亡从ctrl细胞中的35.0%增加到HepG2细胞中的56.9%(32μM)和48.0%(64μM)。细胞周期分析[2]细胞系:HepG2和Huh7细胞浓度:32和64μM孵育时间:24、48和72小时结果:与对照肿瘤细胞相比,CDK1、CDK2、CDK4和细胞周期素D1和E表达下调。 |
| 体内研究 | 辛伐他汀酸(口服灌胃;15和30 mg/kg;每日一次;14 d)治疗可减轻氧化损伤、TNF-a和IL-6水平,并恢复线粒体酶复合物活性[3]。动物模型:雄性wistar大鼠纹状体内6-OHDA给药造成氧化损伤[3]剂量:15和30mg/kg给药:口服灌胃;每日一次;14天结果:与6-OHDA组相比,减轻了氧化损伤(降低了MDA、亚硝酸盐水平并恢复了还原的GSH),降低了TNF-a和IL-6水平,并恢复了线粒体酶复合物活性。 |
| 参考文献 |
| 密度 | 1.13g/cm3 |
|---|---|
| 沸点 | 607ºC at 760mmHg |
| 分子式 | C25H40O6 |
| 分子量 | 436.58200 |
| 闪点 | 198.2ºC |
| 精确质量 | 436.28200 |
| PSA | 104.06000 |
| LogP | 4.10570 |
| 蒸汽压 | 2.89E-17mmHg at 25°C |
| 折射率 | 1.536 |
| 上游产品 8 | |
|---|---|
| 下游产品 1 | |